RavenQuest Announces Formal Agreement With Western Agripharma Limited

Print
| Source: RavenQuest Biomed Inc.

VANCOUVER, British Columbia, Nov. 10, 2017 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) is pleased to announce it has entered into an agreement with Western Agripharma Limited to provide management and consultancy services relating to:

  • Cannabis Licensing Application Development
  • Geotechnical, Engineering and Architecture of licensed Cannabis production facility
  • Design and construction of flagship facility estimated at 125,000 square feet
  • Implementation of RavenQuest’s proprietary growing, drying and automation technology in the new facility

While less than 3% of applicants nationwide have ultimately become licensed to legally produce Cannabis, our organization brings an impressive track record in guiding our clients through the complex licensing process.  We have a 100% success rate in bringing clients from the pre-license inspection letter stage through the intricate construction phase and ultimately to licensed producer status.  As industry participants become increasingly aware of the challenges inherent in the application process, we expect our organization to emerge as the trusted provider of end-to-end Cannabis solutions across Canada.   We appreciate Western Agripharma Limited as the first of many partners of RQB’s Management Services division.  We expect to make several more similar announcements over the next 60 days” said George Robinson, CEO of RavenQuest.

Commenting on the agreement, Western Agripharma President & CEO, Kevin Smith, stated “this decision comes after an extensive due diligence process.  Only after meeting with the foremost consultants throughout the country did we choose to move forward with RavenQuest.  We feel there is currently no other consulting agency in the space with as strong and comprehensive an offering.  We have tremendous confidence in RavenQuest’s industry-leading expertise related to the licensing and production process, and hope to employ their proprietary growing, drying and automation technology, enabling us to produce a superior Cannabis end-product with low cost and minimal environmental footprint.  We are looking forward to a long-term partnership as our two companies continue to grow.”

About RavenQuest Biomed Inc.

RavenQuest Biomed Inc. is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development.

For further details on the Company readers are referred to the Company's web site (www.rqbglobal.com) and its Canadian regulatory filings on SEDAR at www.sedar.com.

On Behalf of the Board of Directors of
RAVENQUEST BIOMED INC.

"George Robinson"
Chief Executive Officer

For further information, please contact:          
Mathieu McDonald, Corporate Communications
1-877-282-1586

Neither Canadian Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Stock Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statements

All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws, including statements with respect to the Company’s ongoing business relationship with Western Agripharma Limited. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited to those identified and reported in the Company’s public filings under the Company’s SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.